These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 26567815

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prediction of new onset of resting pulmonary arterial hypertension in systemic sclerosis.
    Voilliot D, Magne J, Dulgheru R, Kou S, Henri C, Caballero L, De Sousa C, Sprynger M, Andre B, Pierard LA, Lancellotti P.
    Arch Cardiovasc Dis; 2016 Apr; 109(4):268-77. PubMed ID: 26898632
    [Abstract] [Full Text] [Related]

  • 3. Determinants of exercise-induced pulmonary arterial hypertension in systemic sclerosis.
    Voilliot D, Magne J, Dulgheru R, Kou S, Henri C, Laaraibi S, Sprynger M, Andre B, Pierard LA, Lancellotti P.
    Int J Cardiol; 2014 May 15; 173(3):373-9. PubMed ID: 24684997
    [Abstract] [Full Text] [Related]

  • 4. Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study.
    Riccieri V, Vasile M, Iannace N, Stefanantoni K, Sciarra I, Vizza CD, Badagliacca R, Poscia R, Papa S, Mezzapesa M, Nocioni M, Valesini G.
    Rheumatology (Oxford); 2013 Aug 15; 52(8):1525-8. PubMed ID: 23671125
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
    Callejas-Rubio JL, Moreno-Escobar E, de la Fuente PM, Pérez LL, Fernández RR, Sánchez-Cano D, Mora JP, Ortego-Centeno N.
    J Rheumatol; 2008 Sep 15; 35(9):1812-6. PubMed ID: 18634147
    [Abstract] [Full Text] [Related]

  • 7. Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.
    Markusse IM, Meijs J, de Boer B, Bakker JA, Schippers HPC, Schouffoer AA, Ajmone Marsan N, Kroft LJM, Ninaber MK, Huizinga TWJ, de Vries-Bouwstra JK.
    Rheumatology (Oxford); 2017 Jul 01; 56(7):1081-1088. PubMed ID: 27940596
    [Abstract] [Full Text] [Related]

  • 8. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
    Thakkar V, Stevens W, Prior D, Rabusa C, Sahhar J, Walker JG, Roddy J, Lester S, Rischmueller M, Zochling J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M.
    Clin Exp Rheumatol; 2016 Jul 01; 34 Suppl 100(5):129-136. PubMed ID: 27214686
    [Abstract] [Full Text] [Related]

  • 9. Prevalence, determinants, and prognostic significance of exercise-induced pulmonary hypertension in patients with hypertrophic cardiomyopathy.
    Hamatani Y, Amaki M, Yonezawa R, Yanagi Y, Jo Y, Amano M, Okada A, Takahama H, Hasegawa T, Kanzaki H, Yasuda S, Izumi C.
    Int J Cardiovasc Imaging; 2019 May 01; 35(5):837-844. PubMed ID: 30623355
    [Abstract] [Full Text] [Related]

  • 10. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.
    Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C, Sulli A, Piette Y, De Keyser F, Cutolo M.
    J Rheumatol; 2013 Dec 01; 40(12):2023-8. PubMed ID: 24128778
    [Abstract] [Full Text] [Related]

  • 11. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
    Chung L, Fairchild RM, Furst DE, Li S, Alkassab F, Bolster MB, Csuka ME, Derk CT, Domsic RT, Fischer A, Frech TM, Gomberg-Maitland M, Gordon JK, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TAJ, Molitor JA, Preston IR, Schiopu E, Shapiro L, Hant F, Silver R, Simms R, Varga J, Steen VD, Zamanian RT.
    Clin Exp Rheumatol; 2017 Dec 01; 35 Suppl 106(4):106-113. PubMed ID: 27908301
    [Abstract] [Full Text] [Related]

  • 12. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG.
    Eur Heart J; 2006 Jun 01; 27(12):1485-94. PubMed ID: 16682379
    [Abstract] [Full Text] [Related]

  • 13. Serum uric acid as a marker of microvascular damage in systemic sclerosis patients.
    Gigante A, Barbano B, Barilaro G, Quarta S, Gasperini ML, Di Mario F, Romaniello A, Amoroso A, Cianci R, Rosato E.
    Microvasc Res; 2016 Jul 01; 106():39-43. PubMed ID: 27003713
    [Abstract] [Full Text] [Related]

  • 14. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C, Praino E, Nivuori M, di Serio F, Lapadula G, Iannone F.
    Int J Rheum Dis; 2017 Jan 01; 20(1):90-96. PubMed ID: 26218502
    [Abstract] [Full Text] [Related]

  • 15. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
    Cavagna L, Caporali R, Klersy C, Ghio S, Albertini R, Scelsi L, Moratti R, Bonino C, Montecucco C.
    J Rheumatol; 2010 Oct 01; 37(10):2064-70. PubMed ID: 20634241
    [Abstract] [Full Text] [Related]

  • 16. Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern.
    Yalçınkaya Y, Adın-Çınar S, Artim-Esen B, Kamalı S, Pehlivan Ö, Öcal L, Deniz G, Inanç M.
    Microvasc Res; 2016 Nov 01; 108():17-21. PubMed ID: 27392528
    [Abstract] [Full Text] [Related]

  • 17. The relationship between nailfold capillaroscopic assessment and telangiectasia score with severity of peripheral vascular involvement in systemic sclerosis.
    Yalcinkaya Y, Pehlivan O, Omma A, Alpay N, Erer B, Kamali S, Ocal L, Inanc M.
    Clin Exp Rheumatol; 2015 Nov 01; 33(4 Suppl 91):S92-7. PubMed ID: 25797836
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis.
    Ciurzyński M, Bienias P, Irzyk K, Rymarczyk Z, Kostrubiec M, Szewczyk A, Glińska-Wielochowska M, Zyłkowska J, Kurzyna M, Pruszczyk P.
    Kardiol Pol; 2011 Nov 01; 69(1):9-15. PubMed ID: 21267956
    [Abstract] [Full Text] [Related]

  • 19. Peripheral microcirculatory abnormalities are associated with cardiovascular risk in systemic sclerosis: a nailfold video capillaroscopy study.
    Pagkopoulou E, Soulaidopoulos S, Triantafyllidou E, Arvanitaki A, Katsiki N, Loutradis C, Karagiannis A, Doumas M, Garyfallos A, Kitas GD, Dimitroulas T.
    Clin Rheumatol; 2021 Dec 01; 40(12):4957-4968. PubMed ID: 34312764
    [Abstract] [Full Text] [Related]

  • 20. Systemic sclerosis with normal or nonspecific nailfold capillaroscopy.
    Fichel F, Baudot N, Gaitz JP, Trad S, Barbe C, Francès C, Senet P.
    Dermatology; 2014 Dec 01; 228(4):360-7. PubMed ID: 24751944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.